Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Pera

Pediatrics Naperville, IL Medical Doctor

NPI 1851335053 CMS profile 174270

4043 S Route 59, Naperville, IL 60564

Open in the dashboard

General payments

$7,037

352 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Pera of Naperville, IL is reported in the CMS Open Payments database as having received $7,037 across 352 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $922 43
2024 General $1,166 45
2023 General $1,413 65
2022 General $1,008 53
2021 General $983 54
2020 General $591 38
2019 General $953 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Pera
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to James Pera were reported at $922. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year James Pera Pediatrics median Middle half National median
2019 $953 $86 $31–$183 $163
2020 $591 $49 $22–$110 $114
2021 $983 $68 $27–$158 $132
2022 $1,008 $77 $30–$173 $149
2023 $1,413 $88 $33–$190 $160
2024 $1,166 $94 $34–$206 $164
2025 $922 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $988 56 payments
  2. Supernus Pharmaceuticals, Inc. $952 33 payments
  3. Corium, Inc. $942 40 payments
  4. Ironshore Pharmaceuticals Inc. $686 36 payments
  5. Pfizer Inc. $373 17 payments
  6. Adlon Therapeutics L.P. $350 20 payments
  7. Merck Sharp & Dohme Corporation $344 20 payments
  8. Neos Therapeutics, LP $318 20 payments
  9. Sanofi Pasteur Inc. $238 11 payments
  10. GlaxoSmithKline, LLC. $224 12 payments
  11. Other $1,622 87 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,032 351 payments
  2. Education $5 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $942 40 payments
  2. QELBREE Psychology $520 26 payments
  3. JORNAY PM $437 23 payments
  4. Qelbree Viloxazine Hydrochloride $431 7 payments
  5. Dyanavel XR Adhd $355 17 payments
  6. ADHANSIA XR $350 20 payments
  7. Dyanavel XR Adhd $325 18 payments
  8. VAXELIS $265 15 payments
  9. VAXNEUVANCE $263 14 payments
  10. Quillivant XR $248 18 payments
  11. Other $4,896 257 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

352 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record